Neuroinflammation and microglial priming in early AD

0.740

APOE, ABCA1, LDLR

Developing APOE4-specific interventions that restore normal microglial lipid metabolism and cholesterol homeostasis could prevent the enhanced inflammatory priming seen in APOE4 carriers. This would i

0.610

CLOCK, BMAL1, PER2

Restoring circadian rhythms through targeted light therapy and chronotherapy could reprogram primed microglia by resetting their metabolic clock, shifting them from pro-inflammatory glycolytic metabol

0.560

GP2, SPIB

Inhibiting or modulating microfold (M) cells in Peyer's patches could prevent gut-derived inflammatory signals and bacterial products from reaching the brain and priming microglia. This approach would

0.550

HMGB1, S100 proteins

Engineering therapeutic nanoparticles or enhancing endogenous systems to specifically scavenge damage-associated molecular patterns (DAMPs) in the brain microenvironment could prevent the chronic acti

0.510

TREM2, complement cascade components

Developing treatments that selectively block the transmission of peripheral inflammatory signals to brain microglia while preserving beneficial peripheral immune responses could prevent microglial pri

0.480

GFAP, S100B

Enhancing astrocyte priming selectively could create a therapeutic window where astrocytes promote microglial Aβ clearance while simultaneously releasing factors that 'erase' pathological microglial m

0.450

Optogenetic constructs, ion channels

Developing interventions that can temporally control microglial activation states—promoting clearance functions during specific windows while suppressing inflammation during others—could optimize micr